Natalizumab adverse events are rare in patients with multiple sclerosis

被引：13

作者：

Fragoso, Yara Dadalti ^{[1
]}

Alves-Leon, Soniza Vieira ^{[2
]}

Arruda, Walter Oleschko ^{[3
]}

Carvalho, Margarete de Jesus ^{[4
]}

Comini-Frota, Elizabeth Regina ^{[5
]}

Correa, Eber Castro ^{[6
]}

Brito Ferreira, Maria Lucia ^{[7
]}

da Gama, Paulo Diniz ^{[8
]}

Gomes, Sidney ^{[9
,10
]}

Magno Goncalves, Marcus Vinicius ^{[11
]}

Kaimen-Maciel, Damacio Ramon ^{[12
]}

Mendes, Maria Fernando ^{[13
]}

Morales, Rogerio Rizo ^{[14
]}

Muniz, Andre ^{[15
]}

Salgado, Pedro Rippel ^{[16
]}

Ruocco, Heloisa Helena ^{[17
]}

Bezerra de Albuquerque, Livia Brito ^{[7
]}

Bidin Brooks, Joseph Bruno ^{[1
]}

Fezer, Leticia ^{[2
]}

Georgetto, Sergio ^{[12
]}

Lopes, Josiane ^{[12
]}

Malfetano, Fabiola Rachid ^{[2
]}

Meira, Isabella D'Andrea ^{[2
]}

Silva Oliveira, Celso Luis ^{[1
]}

Meneses de Oliveira, Francisco Tomaz ^{[9
,10
]}

Safanelli, Fabiana ^{[11
]}

Satomi, Massaco ^{[16
]}

机构：

[1] Univ Metropolitana Santos UNIMES, Santos, SP, Brazil

[2] Univ Fed Rio de Janeiro UFRJ, Rio De Janeiro, RJ, Brazil

[3] Univ Fed Parana UFPR, Curitiba, PR, Brazil

[4] Fac Med ABC FMABC, Santo Andre, SP, Brazil

[5] Univ Fed Minas Gerais UFMG, Belo Horizonte, MG, Brazil

[6] CLINEN, Brasilia, DF, Brazil

[7] Hosp Restauracao, Recife, PE, Brazil

[8] Pontificia Univ Catolica Sao Paulo PUC SP, Sorocaba, SP, Brazil

[9] Hosp Beneficencia Portuguesa Sao Paulo, Sao Paulo, Brazil

[10] Hosp Paulistano, Sao Paulo, Brazil

[11] Univ Regiao Joinville UNIVILLE, Joinville, SC, Brazil

[12] Univ Estadual Londrina UEL, Londrina, PR, Brazil

[13] Fac Ciencias Med Santa Casa Sao Paulo FCMSCSP, Sao Paulo, Brazil

[14] Univ Fed Uberlandia UFU, Uberlandia, MG, Brazil

[15] Hosp Sao Rafael Salvador, Salvador, BA, Brazil

[16] Univ Fed Mato Grosso Sul UFMS, Campo Grande, MS, Brazil

[17] Ctr Atendimento Esclerose Multipla, Jundiai, SP, Brazil

来源：

ARQUIVOS DE NEURO-PSIQUIATRIA | 2013年 / 71卷 / 03期

关键词：

multiple sclerosis; natalizumab; adverse events; antibodies; monoclonal; INFUSION REACTIONS;

D O I：

10.1590/S0004-282X2013000300002

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Objective: To assess the prevalence and the profile of adverse events (AE) of natalizumab in patients with multiple sclerosis (MS). Methods: Data collection from neurologists attending to patients with MS at specialized units in Brazil. Results: Data from 103 patients attending the infusion centers of 16 MS units in 9 Brazilian states were included in the study. The total number of infusions was 1,042. Seventy-nine patients (76.7%) did not present any AE. Twenty-four patients (23.3%) presented only mild AE. There were three major AE, including two deaths. These three occurrences, although not necessarily being drug-related, must be taken into consideration. Conclusion: The profile of AEs for natalizumab shows that 97% of patients have none or only mild AE. However, still due to safety worries, the use of this medication should be restricted to MS units under the care of specialized neurologists.

引用

页码：137 / 141

页数：5

共 50 条

[1] The profile of natalizumab adverse events in patients with multiple sclerosis
Fragoso, Yara Dadalti
Alves-Leon, Soniza Vieira
Arruda, Walter Oleschko
Carvalho, Margatere de Jesus
Comini-Frota, Elizabeth Regina
Correa, Eber Castro
Brito Ferreira, Maria Lucia
da Gama, Paulo Diniz
Gomes, Sidney
Magno Goncalves, Marcus Vinicius
Kaimen-Maciel, Ramon Damasio
Mendes, Maria Fernanda
Morales, Rogerio Rizo
Muniz, Andre
Salgado, Pedro Rippel
Ruocco, Heloisa Helena
Bidin Brooks, Joseph Bruno
Fezer, Letcia
Georgetto, Sergio
Lopes, Josiane
Malfetano, Fabiola Rachid
Meira, Isabella D'Andrea
Silva Oliveira, Celso Luis
Meneses de Oliveira, Francisco Tomaz
Safanelli, Fabiana
Satomi, Massaco
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1867 - 1868
[2] Effectiveness and Adverse Events of Use of Natalizumab in a Brazilian Cohort of Patients With Multiple Sclerosis
Deslandes, M. Q.
Alves, P. T.
Alvarenga, M. P.
Lessa, V. C. C.
Camargo, S.
Alvarenga, R. M. P.
Vasconcelos, Claudia C.
CLINICAL THERAPEUTICS, 2020, 42 (07) : 1292 - 1301
[3] Adverse working events in patients with multiple sclerosis
Chiara Concetta Incerti
Ornella Argento
Giuseppe Magistrale
Elisabetta Ferraro
Carlo Caltagirone
Valerio Pisani
Ugo Nocentini
Neurological Sciences, 2017, 38 : 349 - 352
[4] Adverse working events in patients with multiple sclerosis
Incerti, Chiara Concetta
Argento, Ornella
Magistrale, Giuseppe
Ferraro, Elisabetta
Caltagirone, Carlo
Pisani, Valerio
Nocentini, Ugo
NEUROLOGICAL SCIENCES, 2017, 38 (02) : 349 - 352
[5] Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events
Calabrese, Massimiliano
Pitteri, Marco
Farina, Gabriele
Bajrami, Albulena
Castellaro, Marco
Magliozzi, Roberta
Monaco, Salvatore
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (12): : 1073 - 1078
[6] Use of Natalizumab in Multiple Sclerosis Patients
O'Connor, Paul W.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2010, 37 (01) : 98 - 104
[7] Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
Cortese, Irene
Ohayon, Joan
Fenton, Kaylan
Lee, Chyi-Chia
Raffeld, Mark
Cowen, Edward W.
DiGiovanna, John J.
Bielekova, Bibiana
NEUROLOGY, 2016, 86 (09) : 847 - 855
[8] Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
LaLive, Patrice
Abbas, Mohamed
Chofflon, Michel
Simon, Hans-Uwe
Chizzolini, Carlo
Ribi, Camillo
NEUROLOGY, 2012, 78
[9] Pain in patients with multiple sclerosis: Effects of natalizumab
Miller, Deborah
Rudick, Richard
Calabresi, Peter
Confavreux, Christian
Galetta, Steven
Giovannoni, Gavin
Havrdova, Eva
Hutchinson, Michael
Kappos, Ludwig
Lublin, Fred
Miller, David
O'Connor, Paul W.
Phillips, Canada J.
Polman, Chris
Radue, Ernst-Wilhelm
Stuart, William
Wajgt, Andrzej
Weinstock-Guttman, Bianca
Wynn, Daniel
Pace, Amy
Hyde, Robert
Kim, Richard
Panzara, Michael
NEUROLOGY, 2008, 70 (11) : A215 - A215
[10] The immunogenicity of natalizumab in patients with multiple sclerosis.
Giovannoni, Gavin
O'Connor, Paul
Havrdova, Eva
Hutchinson, Michael
Kappos, Ludwig
Miller, David
PhillipS, J. Theodore
Polman, Chris
Lublin, Fred
Wajgt, Andrzej
Lynn, Frances
Panzara, Michael
Sandrock, Alfred
CLINICAL IMMUNOLOGY, 2006, 119 : S116 - S116

← 1 2 3 4 5 →